Cargando…
Novel de novo AVPR2 Variant in a Patient with Congenital Nephrogenic Diabetes Insipidus
Early diagnosis and treatment of congenital nephrogenic diabetes insipidus (CNDI) are essential due to the risk of intellectual disability caused by repeated episodes of dehydration and rapid rehydration. Timely genetic testing for disease-causing variants in the arginine vasopressin receptor 2 (AVP...
Autores principales: | Joshi, Shivani, Brandstrom, Per, Gregersen, Niels, Rittig, Søren, Christensen, Jane Hvarregaard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696758/ https://www.ncbi.nlm.nih.gov/pubmed/29177155 http://dx.doi.org/10.1159/000480009 |
Ejemplares similares
-
Novel Variant of AVPR2 Giving Rise to X-Linked Congenital Nephrogenic Diabetes Insipidus in a 7-Month-Old Danish Boy
por: Sollid, Johanne Emy, et al.
Publicado: (2020) -
Four Japanese Patients with Congenital Nephrogenic Diabetes Insipidus due to the AVPR2 Mutations
por: Namatame-Ohta, Noriko, et al.
Publicado: (2018) -
A Novel Mutation in the AVPR2 Gene Causing Congenital Nephrogenic Diabetes Insipidus
por: Çelebi Tayfur, Aslı, et al.
Publicado: (2018) -
A de novo novel missense mutation in AVPR2 with severe nephrogenic diabetes insipidus
por: Kobayashi, Daisuke, et al.
Publicado: (2010) -
A novel mutation in AVPR2 causing congenital nephrogenic diabetes insipidus with complete resistance to antidiuretic hormone
por: Staffler, Alex, et al.
Publicado: (2009)